# IKENA ONCOLOGY INC (IKNA)

> Institutional ownership reported to the SEC as of Q2 2025, from Form 13F filings. Source: https://holderbook.com/stocks/IKNA/

- Reporting holders: 41
- Reported value: $42.6M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Atlas Venture Life Science Advisors, LLC](https://holderbook.com/funds/1917529-atlas-venture-life-science-advisors-llc/) | $6.7M | 5,018,178 | 1.0% | 15 |
| [Blue Owl Capital Holdings LP](https://holderbook.com/funds/1858703-blue-owl-capital-holdings-lp/) | $5.5M | 4,091,118 | 1.8% | 7 |
| [BML Capital Management, LLC](https://holderbook.com/funds/1616824-bml-capital-management-llc/) | $5.4M | 4,030,102 | 4.1% | 5 |
| [BVF INC/IL](https://holderbook.com/funds/1056807-bvf-inc-il/) | $5.4M | 4,006,564 | 0.2% | 18 |
| [ORBIMED ADVISORS LLC](https://holderbook.com/funds/1055951-orbimed-advisors-llc/) | $4.7M | 3,539,358 | 0.1% | 18 |
| [Deep Track Capital, LP](https://holderbook.com/funds/1856083-deep-track-capital-lp/) | $3.4M | 2,515,513 | 0.1% | 2 |
| [Omega Fund Management, LLC](https://holderbook.com/funds/1637359-omega-fund-management-llc/) | $3.0M | 2,249,123 | 2.0% | 18 |
| [VANGUARD GROUP INC](https://holderbook.com/funds/102909-vanguard-group-inc/) | $1.9M | 1,413,649 | 0.0% | 18 |
| [ADAGE CAPITAL PARTNERS GP, L.L.C.](https://holderbook.com/funds/1165408-adage-capital-partners-gp-l-l-c/) | $1.1M | 800,000 | 0.0% | 9 |
| [NEA Management Company, LLC](https://holderbook.com/funds/1512848-nea-management-company-llc/) | $804.1K | 600,063 | 0.1% | 8 |
| [Sofinnova Investments, Inc.](https://holderbook.com/funds/1631134-sofinnova-investments-inc/) | $512.7K | 382,616 | 0.0% | 8 |
| [BlackRock, Inc.](https://holderbook.com/funds/2012383-blackrock-inc/) | $479.6K | 357,936 | 0.0% | 4 |
| [GILEAD SCIENCES, INC.](https://holderbook.com/funds/882095-gilead-sciences-inc/) | $467.1K | 348,534 | 0.0% | 3 |
| [RENAISSANCE TECHNOLOGIES LLC](https://holderbook.com/funds/1037389-renaissance-technologies-llc/) | $413.9K | 308,856 | 0.0% | 6 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1214717-geode-capital-management-llc/) | $412.8K | 307,972 | 0.0% | 17 |
| [Aldebaran Capital, LLC](https://holderbook.com/funds/1448430-aldebaran-capital-llc/) | $324.4K | 242,116 | 0.3% | 2 |
| [ACADIAN ASSET MANAGEMENT LLC](https://holderbook.com/funds/916542-acadian-asset-management-llc/) | $278.0K | 209,568 | 0.0% | 13 |
| [JACOBS LEVY EQUITY MANAGEMENT, INC](https://holderbook.com/funds/884414-jacobs-levy-equity-management-inc/) | $265.5K | 198,107 | 0.0% | 10 |
| [CITADEL ADVISORS LLC](https://holderbook.com/funds/1423053-citadel-advisors-llc/) | $212.0K | 158,215 | 0.0% | 18 |
| [BRIDGEWAY CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1107261-bridgeway-capital-management-llc/) | $205.4K | 153,300 | 0.0% | 13 |
| [TWO SIGMA ADVISERS, LP](https://holderbook.com/funds/1478735-two-sigma-advisers-lp/) | $193.1K | 144,100 | 0.0% | 6 |
| [STATE STREET CORP](https://holderbook.com/funds/93751-state-street-corp/) | $123.5K | 92,153 | 0.0% | 17 |
| [Squarepoint Ops LLC](https://holderbook.com/funds/1642575-squarepoint-ops-llc/) | $113.5K | 84,680 | 0.0% | 3 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $100.0K | 74,661 | 0.0% | 10 |
| [GOLDMAN SACHS GROUP INC](https://holderbook.com/funds/886982-goldman-sachs-group-inc/) | $89.3K | 66,664 | 0.0% | 10 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 56 | $42.9M |
| Q4 2023 | 54 | $64.0M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $97.6M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 41 | $97.8M |